je.st
news
Zacks Investment Research Upgrades QLT Inc. (QLTI) to "Buy"
2016-01-18 04:09:42| Biotech - Topix.net
The firm presently has a $2.75 price objective on the stock. Zacks Investment Research 's target price suggests a potential upside of 13.64% from the stock's current price.
Tags: buy
research
investment
upgrades
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||